Tag: drug delivery

May 20, 2018

Cannabis Weekly Round-Up: Aurora Wants to Buy MedReleaf for C$3.2 Billion

The Investing News Network rounds up some of the biggest company and market news in the cannabis market for the...
May 14, 2018

Canadian Cannabis Stocks

The Canadian cannabis space is one of the hottest growing sectors. Here's a look at Canadian cannabis stocks for investors...
May 13, 2018

5 Top Weekly NASDAQ Biotech Stocks: Helius Up 43.19 Percent

Helius Medical Technologies, vTv Therapeutics, Second Sight Medical Products, Depomed and Senomyx were last week's top gainers on the NASDAQ.
April 30, 2018

Lexaria Technology Brings “Fast-Acting” to Nuka’s 1906 Cannabis Products with 10-Year Deal Consummating Proof-of-Concept Relationship

Lexaria Bioscience Corp. (CSE:LXX,OTCQB:LXRP), an innovator in drug delivery platforms, today announced a major new licensing agreement with Nuka Enterprises...
April 29, 2018

5 Top Weekly NASDAQ Biotech Stocks: Eleven Biotherapeutics Up 45 Percent

Eleven Biotherapeutics, EyePoint Pharmaceuticals, Avid Bioservices, Cerecor and Celldex were last week's top gainers on the NASDAQ.
April 29, 2018

5 Top Weekly NASDAQ Biotech Stocks: Eiger BioPharmaceuticals Leads with 81.62 Percent

Eiger BioPharmaceuticals, Arqule, Galectin Therapeutics, MEI Pharma and BioDelivery Sciences were last week's top gainers on the NASDAQ.
April 29, 2018

Cannabis Weekly Round-Up: 3 New Cannabis Stocks Set to Launch in Canada

The Investing News Network rounds up some of the biggest company and market news in the cannabis market for the...
April 27, 2018

Cannabis Weekly Round-Up: 3 New Cannabis Stocks Set to Launch in Canada

The Investing News Network rounds up some of the biggest company and market news in the cannabis market for the...
April 27, 2018

Lexaria Announces LOI with Hill Street Beverage Co. for Cannabis Infused Alcohol-Free Beer and Wine

Lexaria Bioscience Corp. (CSE:LXX,OTCQB:LXRP) (the "Company" or "Lexaria"), a drug delivery platform innovator, announces that it has entered a Letter...
April 25, 2018

Daré Bioscience and Juniper Pharmaceuticals Enter Global License Agreement

In early trading on Wednesday, Daré’s share price increased nearly 73 percent before leveling at a 56.69-percent increase.